Inovio Pharma (INO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 26,272 | 44,273 | 36,567 | 24,351 | 39,916 |
| Marketable Securities | 11,410 | 14,239 | 14,236 | 23,198 | 28,447 |
| Receivables | N/A | N/A | 979 | 840 | 1,310 |
| TOTAL | $39,440 | $61,123 | $55,180 | $52,697 | $71,895 |
| Non-Current Assets | |||||
| PPE Net | 2,211 | 2,528 | 2,740 | 3,089 | 3,348 |
| Investments And Advances | 0 | 2,104 | 2,496 | 3,085 | 2,309 |
| Other Non-Current Assets | 8,127 | 8,555 | 8,969 | 9,369 | 9,721 |
| TOTAL | $10,338 | $13,187 | $14,205 | $15,543 | $15,378 |
| Total Assets | $49,777 | $74,310 | $69,386 | $68,241 | $87,273 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 9,267 | 11,128 | 15,703 | 16,120 | 13,389 |
| Accrued Expenses | 817 | 651 | 956 | 1,511 | 1,819 |
| Other current liabilities | 24,930 | 29,067 | 50,384 | 11,420 | 9,542 |
| TOTAL | $37,923 | $43,669 | $69,824 | $31,708 | $27,327 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | 42 | N/A | N/A |
| Other Non-Current Liabilities | 5,786 | 6,545 | 7,282 | 8,002 | 8,695 |
| TOTAL | $5,786 | $6,545 | $7,282 | $8,002 | $8,695 |
| Total Liabilities | $43,709 | $50,214 | $77,106 | $39,710 | $36,022 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 82,273 | 69,092 | 53,572 | 53,143 | 36,674 |
| Common Shares | 70 | 69 | 54 | 37 | 37 |
| Retained earnings | -1,834,848 | -1,815,165 | -1,818,930 | -1,773,433 | -1,749,914 |
| Other shareholders' equity | -636 | -638 | -648 | -662 | -661 |
| TOTAL | $6,068 | $24,096 | $-7,720 | $28,531 | $51,251 |
| Total Liabilities And Equity | $49,777 | $74,310 | $69,386 | $68,241 | $87,273 |